Welcome to BlogNotions' Life Sciences Blog

The BlogNotions Life Sciences Blog delivers a diverse series of perspectives provided by thought leaders in the life sciences industries. Presented by NetLine, this forum delivers compelling updates on the latest technological advances, discussions of research and findings, best practices for advancing education, implications for the future of various life sciences fields, and much more. Here you can find helpful information, ask questions, and collaborate freely.

New drug holds potential for treating advanced mastocytosis

In continuation of my update on Midostaurin  Most people have never heard of mastocytosis. It’s a rare, sometimes deadly, immune disorder. Now new research may help those with advanced mastocytosis and possibly many more people, too. “This is the first drug that’s shown to be effective in this very rare disease,” says Tracy George, MD, at […]

Continue Reading

Drug Patent Expirations for Jun 22, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. STIOLTO RESPIMAT (olodaterol hydrochloride; tiotropium bromide) Boehringer Ingelheim Patent number: 6,149,054 Expiration Date: Jun 19, 2017 VENTOLIN HFA (albuterol sulfate) Glaxosmithkline Patent number: 6,558,651 Expiration Date: […]

Continue Reading

Edible ginger-derived nano-lipids could effectively deliver drugs for treating colon cancer

Edible ginger-derived nano-lipids created from a specific population of ginger nanoparticles show promise for effectively targeting and delivering chemotherapeutic drugs used to treat colon cancer, according to a study by researchers at the Institute for Biomedical Sciences at Georgia State University, the Atlanta Veterans Affairs Medical Center and Wenzhou Medical University and Southwest University in […]

Continue Reading

Vitamin A Compound Might Aid in Colon Cancer Fight

In continuation of my update on Retinoic acid Retinoic acid, a compound derived in the body from vitamin A, might have a role in suppressing colon cancer, new animal research suggests. “Retinoic acid has been known for years to be involved in suppressing inflammation in the intestine,” said study senior author Dr. Edgar Engleman, professor of […]

Continue Reading

Combo Drug for Childhood Asthma Appears Safe in Study

In continuation of my update on fluticasone  Lingering safety concerns regarding an asthma drug for children may be put to rest by new clinical trial results showing the widely used medication is safe, according to a new report. Long-acting beta agonists (LABAs) provide short-term relief of asthma symptoms by relaxing and opening the airways. They’re prescribed to child […]

Continue Reading

Newer Epilepsy Drugs May Be Safer During Pregnancy

In continuation of my update on  levetiracetam and topiramate    Topiramate    Levetiracetam  Women who take the new epilepsy drugs levetiracetam and topiramate during pregnancy don’t run the risk of harming their infant’s mental development, British researchers report. But the commonly prescribed anti-seizure drug valproate was linked with lower IQs in children, especially when taken at higher doses, researchers say. “The treatment of epilepsy in women […]

Continue Reading

Patenting the Microbiome – Part 2: Microbiome IP Panel, 2017 BIO Convention

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below.  Given the increasing focus on microbiome technologies for better, safer therapies, and critical importance of Intellectual Property (IP) protection for their full commercialization, it is great to see the 2017 […]

Continue Reading

Drug Patent Expirations for Jun 15, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. INOMAX (nitric oxide) Mallinckrodt Hosp Patent number: 5,732,693 Expiration Date: Jun 13, 2017 INOMAX (nitric oxide) Mallinckrodt Hosp Patent number: 5,752,504 Expiration Date: Jun 13, 2017 […]

Continue Reading

Researchers identify promising new drug treatment for cocaine addiction

A team of researchers led by Cardiff University has discovered a promising new drug treatment for cocaine addiction. The experimental therapy, which involves administering a drug currently used in cancer therapy trials, treats cocaine addiction by inhibiting memories responsible for cravings. Professor Riccardo Brambilla from Cardiff University’s School of Biosciences said: “We have demonstrated that […]

Continue Reading

Drug Patent Expirations for Jun 15, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. INOMAX (nitric oxide) Mallinckrodt Hosp Patent number: 5,732,693 Expiration Date: Jun 13, 2017 INOMAX (nitric oxide) Mallinckrodt Hosp Patent number: 5,752,504 Expiration Date: Jun 13, 2017 […]

Continue Reading